Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $86.64 -0.95%
Financial Fact:
OPERATING LOSS: -19.34M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
OPERATING LOSS: -19.34M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of ($0.93), $0.11 better than the analyst estimate of ($1.04). Revenue for the quarter came in at $73.74 million versus the consensus estimate of $71.5 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- SEC accuses ex-BofA senior banker Satsky of insider trading - Bloomberg
- Popular stocks with increasing option volume: SPCX MSTR PLTR MU HOOD MRNA SOFI BABA INTC WMT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
